Literature DB >> 20186933

Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a.

S Rodrigues, F Magro, J Soares, A C R Nunes, S Lopes, M Marques, E Rio, G Macedo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20186933     DOI： 10.1002/ibd.21242

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  4 in total

1.  Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis.

Authors:  Adelle P McFarland; Ram Savan; Sagie Wagage; Augustina Addison; Karthika Ramakrishnan; Megan Karwan; Tri Duong; Howard A Young
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

Review 2.  The Protective Role of Type I Interferons in the Gastrointestinal Tract.

Authors:  Kevin P Kotredes; Brianna Thomas; Ana M Gamero
Journal:  Front Immunol       Date:  2017-04-06       Impact factor: 7.561

3.  Multiple sclerosis and inflammatory bowel disease: A systematic review and meta-analysis.

Authors:  Xuan Wang; Jian Wan; Min Wang; Yujie Zhang; Kaichun Wu; Fang Yang
Journal:  Ann Clin Transl Neurol       Date:  2022-01-29       Impact factor: 4.511

4.  Stimulator of interferon genes (STING) activation exacerbates experimental colitis in mice.

Authors:  Gary R Martin; Charlene M Blomquist; Kimiora L Henare; Frank R Jirik
Journal:  Sci Rep       Date:  2019-10-03       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.